Could a weight loss drug ease long COVID's debilitating fatigue?
Symptom relief
Ongoing
This study is testing whether the medication tirzepatide (brand name Zepbound) can reduce symptoms of Long COVID, especially severe fatigue. It involves 1,000 adults in the U.S. with Long COVID who will be randomly assigned to take either the real medication or a placebo pill for…
Phase: PHASE2 • Sponsor: Scripps Translational Science Institute • Aim: Symptom relief
Last updated Mar 30, 2026 14:28 UTC